Clinical features, microbiology and surgical outcomes of infective endocarditis: A 13-year study from a UK tertiary cardiothoracic referral centre

QJM: An International Journal of Medicine

Volumn 108, Issue 3, 2015, Pages 219-229

  Marks, D J B ^a   Hyams, C ^a   Koo, C Y ^a   Pavlou, M ^a   Robbins, J ^a   Koo, C S ^a   Rodger, G ^a   Huggett, J F ^a   Yap, J ^b   Macrae, M B ^b   Swanton, R H ^b   Zumla, A I ^a,b   Miller, R F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; UREA;

ACTINOBACILLUS; ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL ABUSE; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOGRAFT; ALPHA HEMOLYTIC STREPTOCOCCUS; AORTA VALVE DISEASE; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; BILIRUBIN BLOOD LEVEL; CARDIOBACTERIUM; CELLULITIS; CENTRAL VENOUS CATHETERIZATION; CLINICAL FEATURE; COHORT ANALYSIS; CONGENITAL HEART DISEASE; COST EFFECTIVENESS ANALYSIS; COXIELLA BURNETII; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSIS; ECHOCARDIOGRAPHY; EIKENELLA; ENTEROBACTERIACEAE; ERYTHROCYTE COUNT; FEMALE; FUNGUS; GENDER; HAEMOPHILUS; HEART SURGERY; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMOGLOBIN BLOOD LEVEL; HOMELESSNESS; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ABUSE; KINGELLA; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MITRAL VALVE DISEASE; MIXED INFECTION; MORTALITY; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; PATIENT HISTORY OF SURGERY; PATIENT REFERRAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC FEVER; SMOKING; STAPHYLOCOCCUS; STEROID THERAPY; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; SURGICAL MORTALITY; THORAX SURGERY; THROMBOCYTE COUNT; TOOTH DISEASE; TREATMENT OUTCOME; UREA BLOOD LEVEL; XENOGRAFT; COMPLICATION; ENDOCARDITIS, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART VALVE DISEASES; MICROBIOLOGY; MIDDLE AGED; MYCOSES; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE;

ADULT; AGED; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYCOSES; PATIENT READMISSION; RETROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 84924455032     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu188     Document Type: Article

References (35)

1. Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363:139-49.
2. Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet 2012; 379:965-75.
3. Ternhag A, Cederstrom A, Torner A, Westling K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS ONE 2013; 8:e67519.
4. Tleyjeh IM, bdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A systematic review of populationbased studies of infective endocarditis. Chest 2007; 132:1025-35.
5. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG, Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169:463-73.
6. Wang A, Athan E, Pappas PA, Fowler VG, Jr, Olaison L, Pare C, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297:1354-61.
7. Fernandez-Guerrero ML, Verdejo C, Azofra J, de Górgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995; 20:16-23.
8. Gould FK, Denning DW, Elliott TS, Foweraker J, Perry JD, Prendergast BD, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2012; 67:269-89.
9. Bonow RO, Carabello BA, Chatterjee K, de Leon ACJ, Faxon DP, Freed MD, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523-e661.
10. Jault F, Gandjbakhch I, Rama A, Nectoux M, Bors V, Vaissier E, et al. Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg 1997; 63:1737-41.
11. Larbalestier RI, Kinchla NM, Aranki SF, Couper GS, Collins JJ, Jr, Cohn LH. Acute bacterial endocarditis. Optimizing surgical results. Circulation 1992; 86(5 Suppl.):II68-II74.
12. Bauernschmitt R, Jakob HG, Vahl CF, Lange R, Hagl S. Operation for infective endocarditis: results after implantation of mechanical valves. Ann Thorac Surg 1998; 65:359-64.
13. Olaison L, Hogevik H, Myken P, Oden A, Alestig K. Early surgery in infective endocarditis. QJM 1996; 89:267-78.
14. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16:9-13.
15. O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009; 88(Suppl. 1):S23-S42.
16. Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 2007; 83:921-9.
17. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-8.
18. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002; 88:53-60.
19. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 2012; 59:1968-76.
20. Desimone DC, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, et al. Incidence of Infective Endocarditis Caused by Viridans Group Streptococci Before and After Publication of the 2007 American Heart Association's Endocarditis Prevention Guidelines. Circulation 2012; 126:60-4.
21. Marks DJ, Fisk MD, Koo CY, Pavlou M, Peck L, Lee SF, et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS ONE 2012; 7:e30074.
22. Thuny F, Giorgi R, Habachi R, Ansaldi S, Le Dolley Y, Casalta JP, et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J 2012; 164:94-101.
23. Gaca JG, Sheng S, Daneshmand MA, O'Brien S, Rankin JS, Brennan JM, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg 2011; 141:98-106.
24. Ohara T, Nakatani S, Kokubo Y, Yamamoto H, Mitsutake K, Hanai S. Clinical predictors of in-hospital death and early surgery for infective endocarditis: Results of CArdiac Disease REgistration (CADRE), a nation-wide survey in Japan. Int J Cardiol 2013; 167:2688-97.
25. Yung D, Kottachchi D, Neupane B, Haider S, Loeb M. Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review. J Antimicrob Chemother 2007; 60:921-8.
26. Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection 2012; 40:527-35.
27. Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012; 54:1230-9.
28. Dzupova O, Machala L, Baloun R, Maly M, Benes J. Incidence, predisposing factors, and aetiology of infective endocarditis in the Czech Republic. Scand J Infect Dis 2012; 44:250-5.
29. Castonguay MC, Burner KD, Edwards WD, Baddour LM, Maleszewski JJ. Surgical pathology of native valve endocarditis in 310 specimens from 287 patients (1985-2004). Cardiovasc Pathol 2013; 22:19-27.
30. John RM, Pugsley W, Treasure T, Sturridge MF, Swanton RH. Aortic root complications of infective endocarditis-influence on surgical outcome. Eur Heart J 1991; 12:241-8.
31. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart 2003; 89:258-62.
32. Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005; 43:5238-42.
33. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore) 2005; 84:162-73.
34. Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis 2012; 31:2905-10.
35. Rabkin DG, Mokadam NA, Miller DW, Goetz RR, Verrier ED, Aldea GS. Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users. Ann Thorac Surg 2012; 93:51-7.